1.
Ann Rheum Dis
; 81(7): e131, 2022 07.
Article
in English
| MEDLINE
| ID: mdl-32586922
Subject(s)
Antirheumatic Agents , Biological Products , COVID-19 , Janus Kinase Inhibitors , Rheumatic Diseases , Antirheumatic Agents/therapeutic use , Biological Products/therapeutic use , Humans , Incidence , Janus Kinase Inhibitors/therapeutic use , Rheumatic Diseases/drug therapy , Rheumatic Diseases/epidemiology
2.
Ann Rheum Dis
; 80(4): e58, 2021 04.
Article
in English
| MEDLINE
| ID: mdl-32471899
3.
Ann Rheum Dis
; 80(6): e92, 2021 06.
Article
in English
| MEDLINE
| ID: mdl-32632033